OverviewChartTechnicalNewsTraderScreen

Aptevo Therapeutics Inc/  US03835L3069  /

NASDAQ
2024-05-20  9:59:20 PM Chg. -0.0560 Volume Bid1:30:45 AM Ask1:30:45 AM High Low
0.7440USD -7.00% 208,636
Turnover: 133,338.9363		 0.7421Bid Size: 3,700 0.7700Ask Size: 100 0.7817 0.7210
GlobeNewswire 2022-03-23 Emergent BioSolutions Provides Corporate Governance Update
GlobeNewswire 2021-11-02 BriaCell Appoints Renowned Pharmaceutical Veteran Jane Gross, Ph.D. to its Board of Directors
GlobeNewswire 2021-06-16 Medexus Revenue Increases 43.5% to a Record US$79.7 Million for Fiscal 2021
GlobeNewswire 2021-03-10 Roth Capital Partners 33rd Annual Conference to be held Virtually March 15-17, 2021
GlobeNewswire 2021-03-01 Medexus Achieves Record Revenue of $31.5 Million for the Third Quarter Fiscal 2021
GlobeNewswire 2020-11-03 iBio Announces Appointment of Randy J. Maddux as Chief Operating Officer
GlobeNewswire 2020-08-26 Emergent BioSolutions Announces Appointment of Marvin White to the Company’s Board of Directors
GlobeNewswire 2020-05-22 Medexus Provides an Update on the IXINITY® Acquisition and its Overall Business in the COVID-19 Envi...
GlobeNewswire 2020-04-20 Zogenix Appoints Shawnte Mitchell as Executive Vice President, General Counsel & Secretary
GlobeNewswire 2020-02-28 Medexus Expands its US Product Portfolio by Acquiring the Hematology Asset IXINITY®
GlobeNewswire 2019-12-06 Aptevo Therapeutics Receives Orphan Drug Designation for APVO436 for the Treatment of Acute Myelogen...
GlobeNewswire 2019-11-08 Aptevo Therapeutics and Alligator Bioscience Present New Preclinical Data for ALG.APV-527 at the Soc...
GlobeNewswire 2019-11-07 Aptevo Therapeutics Reports Third Quarter 2019 Financial Results
GlobeNewswire 2019-10-03 Aptevo Therapeutics Provides Corporate and Pipeline Update
GlobeNewswire 2019-08-09 Aptevo Therapeutics Reports Second Quarter 2019 Financial Results
GlobeNewswire 2019-08-07 Aptevo Therapeutics Receives $4.3 Million Milestone Payment From Saol International Limited
GlobeNewswire 2019-07-25 Aptevo Therapeutics Reports Continued Progress In APVO210 and APVO436 Clinical Trials
GlobeNewswire 2019-07-01 aTyr Pharma Strengthens Board of Directors with the Appointment of Two New Members
GlobeNewswire 2019-06-21 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market 2019
GlobeNewswire 2019-05-09 Aptevo Therapeutics Reports First Quarter 2019 Financial Results
GlobeNewswire 2019-04-23 United States Biosimilars Market 2019-2025 Dosage, Price & Clinical Pipeline Outlook - A $5 Billion ...
GlobeNewswire 2019-04-18 Research Report Identifies Fastenal, Ideal Power, Fuel Tech, CTI BioPharma, Aptevo Therapeutics, and...
GlobeNewswire 2019-04-15 Aptevo Therapeutics Reports IXINITY® and Pipeline Progress
GlobeNewswire 2019-04-02 Aptevo Therapeutics Presents New Preclinical Data for APVO436 and ALG.APV-527 at the American Associ...
GlobeNewswire 2019-03-25 Aptevo Therapeutics to Present New Preclinical Data for APVO436 and ALG.APV.527 at the American Asso...